Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use
of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human …

One of the most effective molecular diversity techniques is phage display. This technology is
based on a direct linkage between phage phenotype and its encapsulated genotype, which …

As compared with peptide-or protein-based vaccines, naked DNA vectors and even
traditional attenuated or inactivated virus vaccines, virus-like particles (VLPs) are an …

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secretory protein that controls
cholesterol homeostasis by enhancing endosomal and lysosomal degradation of the low …

Ever since the development of the first vaccine, vaccination has had the great impact on
global health, leading to the decrease in the burden of numerous infectious diseases …

Virus-like particle (VLP) technology is a promising approach for the construction of novel
vaccines, diagnostic tools, and gene therapy vectors. Initially, VLPs were primarily derived …

Cervical cancer is an important public health problem worldwide, and especially in
developing countries. The link between cervical cancer and oncogenic human …

Prophylactic vaccines capable of preventing human papillomavirus (HPV) infections are still
inaccessible to a vast majority of the global population due to their high cost and challenges …

Genome packaging is an essential step in virus replication and a potential drug target.
Single-stranded RNA viruses have been thought to encapsidate their genomes by gradual …

Licensed human papillomavirus (HPV) vaccines contain virus-like particles (VLPs) self-
assembled from L1 major-capsid proteins that are remarkably effective prophylactic …